Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Oct;41(2):483-9.

Target-effector interaction in the natural killer (NK) cell system. VI. The influence of age and genotype on NK binding characteristics

Target-effector interaction in the natural killer (NK) cell system. VI. The influence of age and genotype on NK binding characteristics

J C Roder. Immunology. 1980 Oct.

Abstract

Four independent assays were used to compare target-cell binding by NK cells in different populations. First, detergent solubilized and reduced proteins from the surface of Moloney lymphoma cells (YAC) were electrophoresed in SDS-polyacrylamide gels. The glycoproteins recognized by NK cells (NK-TS) were eluted from the gels and used in semi-quantitative absorption studies or were used to inhibit the formation of target-effector conjugates as an estimate of relative avidity. These findings were supported by a comparative analysis of cold target competition curves and saturation studies in which 51Cr-labelled target cells were carefully titrated. The results suggest that NK cells 'mature' during ontogeny to higher avidity binding whereas the decline in NK function during senescence can solely be attributed to a decrease in population size. A comparison of high (CBA) and low (A/Sn) NK reactive strains revealed that in low responder (i) absolute NK frequency was decreased, (ii) relative NK-TS absorption per NK cells was low, and (iii) relative avidity of NK cells was identical to that in the high responder strain. These results suggest that the putative NK receptor to YAC may be of restricted heterogeneity.

PubMed Disclaimer

References

    1. J Immunol. 1971 Dec;107(6):1558-66 - PubMed
    1. Eur J Immunol. 1975 Feb;5(2):112-7 - PubMed
    1. Nature. 1977 Dec 15;270(5638):609-11 - PubMed
    1. Nature. 1978 Jun 29;273(5665):759-61 - PubMed
    1. Adv Cancer Res. 1978;27:305-77 - PubMed

Publication types

LinkOut - more resources